Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Family-partnered Delirium Prevention, Detection, and Management in the ICU: A Stepped-wedge Cluster Randomized Trial

NCT07896356 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT07896356 Not yet recruiting Not applicable 1,344 participants (estimated) Started 2027 1 site

Follow this trial by email Email me the PDF

Get the NCT07896356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Summary

Not yet recruiting, started February 2027. Interventional study, 1,344 participants (estimated). Lead sponsor University of Calgary; Canada. Primary measure: Family member symptoms of depression and anxiety.

How it compares

333 similar trials: same condition (Delirium) and phase

Enrollment

This trial
1,344
Middle half
60 to 266
Median
116
Trials with a value
333

Months from start to completion

This trial
36
Middle half
12 to 44.8
Median
24
Trials with a value
333

Sites

This trial
1
Middle half
1 to 1
Median
1
Trials with a value
303
Posted results or a linked paper 56% 186 of 333 similar trials; this trial: no

Registry record

As filed in ClinicalTrials.gov.

Title
Family-partnered Delirium Prevention, Detection, and Management in the ICU: A Stepped-wedge Cluster Randomized Trial
Lead sponsor
University of Calgary
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 1, 2027
Completion date
February 1, 2030
Enrollment
1,344 (estimated)
Sites
1

Conditions

MeSH condition names; the registry's own terms follow.

Critical Illness, Delirium

Registry terms: intensive care unit delirium, post intensive care unit syndrome, post intensive care unit syndrome family

Who could take part, where it ran, who ran it

As filed in ClinicalTrials.gov.

Sex
All
Minimum age
18 Years
Healthy volunteers
No
Study type
Interventional
Sites
1
Countries
Canada
Lead sponsor
University of Calgary

Arms

As registered; 2 arms.

Registered arms
Arm Type Interventions
Control Group Placebo comparator Standard of Care
Show registry wording

Patients and family caregivers will receive standard of care, which varies by study site, but includes guideline-recommended interventions by the clinical team to prevent and manage delirium.

Intervention Group Experimental Delirium Education, Prevention, and Management, Standard of Care
Show registry wording

Patients and family caregivers will receive standard of care, which varies by study site, but includes guideline-recommended interventions by the clinical team to prevent and manage delirium. Additionally, they will receive a family-partnered delirium care intervention comprised of two components: 1) Education and 2) Family administered delirium prevention, detection, and management activities.

Primary endpoints

Registered primary outcome measures; 1 primary.

Registered primary endpoints
Measure Time frame
Family member symptoms of depression and anxiety 3-months post-ICU discharge
Show registry wording

Change in the proportion of major depressive disorder and generalized anxiety symptamology in family members of critical ill patients measured by the Patient Health Questionnaire-Anxiety and Depression Scale (PHQ-ADS) scores, compared between control and intervention

Lead sponsor's other trials

University of Calgary, most recent start first.

Similar trials

Same condition (Delirium) and phase, most recent start first.